BRCA2 (breast cancer susceptibility gene 2) was identified in 1995 by Wooster and colleagues, by analyzing BRCA1 mutation-negative breast cancer families, including male patients with breast cancer [11]. This evidence concerns the gene BRCA1 and breast carcinoma.